Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease
- 31 July 2005
- Vol. 66 (1) , 156-160
- https://doi.org/10.1016/j.urology.2005.01.008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate CancerJournal of Urology, 2003
- Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor featuresUrology, 2002
- Lower Prostate Specific Antigen Outcome Than Expected Following Radical Prostatectomy in Patients With High Grade Prostate and a Prostatic Specific Antigen Level of 4 Ng/Ml. or LessJournal of Urology, 2002
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGENJournal of Urology, 2000
- The early detection of prostate carcinoma with prostate specific antigenCancer, 1997
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic TestsJournal of Urology, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991